title: Hepatitis B and NAFLD: Lives Crossed.
abstract: Hepatitis B virus infection seems to protect against steatosis and insulin resistance decreasing NAFLD. Metabolic syndrome has been associated with increased risk of disease progression to cirrhosis and liver cancer in hepatitis B. HBsAg seroclearance increased over time and it could be a confounding factor when analysing NAFLD and hepatitis B prevalence.
authors.affiliation: Intercentres Mac.Ro UCM Digestive Diseases, University Hospitals Virgen Macarena y Virgen del Rocío, University of Seville, Institute of Biomedicine of Seville and CIBEREHD. Sevilla, Spain.
authors.forename: María L
authors.initials: MR
authors.lastname: Morales
authors.affiliation: Intercentres Mac.Ro UCM Digestive Diseases, University Hospitals Virgen Macarena y Virgen del Rocío, University of Seville, Institute of Biomedicine of Seville and CIBEREHD. Sevilla, Spain.
authors.forename: Carmen
authors.initials: C
authors.lastname: Sendra
authors.affiliation: Intercentres Mac.Ro UCM Digestive Diseases, University Hospitals Virgen Macarena y Virgen del Rocío, University of Seville, Institute of Biomedicine of Seville and CIBEREHD. Sevilla, Spain.
authors.forename: Manuel
authors.initials: M
authors.lastname: Romero-Gomez
mesh_terms: D006509:Hepatitis B; D006514:Hepatitis B Surface Antigens; D006515:Hepatitis B virus; D019694:Hepatitis B, Chronic; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease
chemical_list: D006514:Hepatitis B Surface Antigens
keywords: HBeAg; HBsAg; Hepatitis B; NAFLD; NASH